LLMpediaThe first transparent, open encyclopedia generated by LLMs

David Shaffer

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Anna Wintour Hop 5
Expansion Funnel Raw 35 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted35
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
David Shaffer
NameDavid Shaffer
Birth date1943
Birth placeNew York City, New York, United States
OccupationPsychiatrist, researcher, academic
FieldsChild and adolescent psychiatry, epidemiology, suicide prevention
InstitutionsColumbia University, NewYork-Presbyterian Hospital, Division of Child and Adolescent Psychiatry
Alma materHarvard College, Columbia University Vagelos College of Physicians and Surgeons
Known forDevelopment of suicide assessment instruments, epidemiologic studies of adolescent suicide, public health interventions

David Shaffer

David Shaffer was an American child and adolescent psychiatrist and epidemiologist noted for pioneering empirical research into youth suicide and for developing standardized assessment tools used worldwide. He combined clinical practice at major medical centers with large-scale epidemiologic studies and policy-oriented interventions, influencing clinical guidelines and public health approaches in pediatrics and psychiatry. His work bridged institutions in academic medicine and national organizations concerned with mental health and suicide prevention.

Early life and education

Shaffer was born in New York City and completed undergraduate studies at Harvard College before earning his medical degree at Columbia University Vagelos College of Physicians and Surgeons. He completed residency training in psychiatry and fellowship work in child and adolescent psychiatry at programs affiliated with NewYork-Presbyterian Hospital and academic departments at Columbia University Irving Medical Center. During early career development he trained with faculty associated with influential programs at Johns Hopkins Hospital and networks connected to the National Institute of Mental Health.

Academic and clinical career

Shaffer held faculty positions in departments of psychiatry and pediatrics at Columbia University and served in leadership roles within child and adolescent psychiatry divisions at major medical centers including NewYork-Presbyterian Hospital. He directed clinical services, supervised trainees from residency and fellowship programs affiliated with American Board of Psychiatry and Neurology and contributed to curricula linked to American Academy of Child and Adolescent Psychiatry. His clinical work intersected with hospital systems, school-based programs, and collaborations with municipal health departments such as the New York City Department of Health and Mental Hygiene, fostering translational links between patient care and community services.

Research on suicide and epidemiology

Shaffer conducted seminal epidemiologic investigations into adolescent suicidal behavior, using methods from psychiatric epidemiology and collaborating with researchers at institutions like Columbia University Mailman School of Public Health and agencies such as the Centers for Disease Control and Prevention. His cohort and case-control studies examined prevalence, risk factors, and diagnostic correlates of suicide attempts and completions among youth, interacting with literature from investigators at Yale School of Medicine, Brown University, and University of California, San Francisco. His work addressed comorbid disorders described in classifications by the American Psychiatric Association and informed surveillance approaches promoted by the World Health Organization.

Development of the Columbia-Suicide Severity Rating Scale

Shaffer led the development of a standardized instrument to assess suicidal ideation and behavior, which was field-tested across clinical sites including emergency departments, inpatient psychiatry units, and outpatient clinics affiliated with Columbia University and partner hospitals. The instrument was validated in studies that referenced diagnostic frameworks from the Diagnostic and Statistical Manual of Mental Disorders and measurement standards advocated by organizations such as the National Institutes of Health. The scale was disseminated through collaborations with professional societies including the American Foundation for Suicide Prevention and used in settings spanning pediatric clinics, military health systems linked to the United States Department of Defense, and international public health programs coordinated with the World Health Organization.

Major publications and awards

Shaffer authored and coauthored influential articles in journals associated with JAMA, The New England Journal of Medicine, The Lancet Psychiatry, and specialty outlets tied to Journal of the American Academy of Child and Adolescent Psychiatry. His books and monographs addressed adolescent psychiatry, suicide prevention, and clinical assessment, and he contributed chapters to textbooks used in training at institutions like Harvard Medical School and Columbia University Vagelos College of Physicians and Surgeons. His contributions were recognized by honors from bodies such as the American Academy of Child and Adolescent Psychiatry, the American Psychiatric Association, and advocacy groups including the American Foundation for Suicide Prevention.

Impact, controversies, and legacy

Shaffer’s work reshaped clinical practice by promoting structured assessment of suicidal ideation and facilitating evidence-based screening protocols adopted by pediatric and psychiatric services at institutions like Boston Children’s Hospital and Children’s Hospital of Philadelphia. His legacy includes widespread adoption of assessment tools in research and practice, influence on guidelines produced by agencies such as the Substance Abuse and Mental Health Services Administration and enduring citation in systematic reviews from groups at Cochrane and international consortia. Controversies have arisen in debates over risk prediction, false positives in screening programs, and implementation across diverse health systems including debates involving the U.S. Preventive Services Task Force and ethics discussions in clinical research oversight by Institutional Review Boards. His methodological emphasis on standardized measurement continues to inform contemporary work on adolescent mental health, suicide prevention policy, and training programs in child and adolescent psychiatry.

Category:American psychiatrists Category:Child and adolescent psychiatrists Category:Suicide prevention